February 24, 2014
Elanco announces an agreement to acquire Lohmann Animal Health, a privately-held company headquartered in Cuxhaven, Germany. The acquisition will establish Elanco as a global poultry leader, extending our presence into layers and expanding our growing vaccine presence.
August 24, 2012
Comfortis® (spinosad), the month-long flavored tablet that has been protecting dogs from fleas since 2007 has now been approved for use in cats and smaller dogs. As a result of the recent FDA approval, Comfortis can now be used in cats and kittens greater than 2 lbs and 14 weeks and older. In addition, our new 90 mg tablet will allow veterinarians to prescribe Comfortis for smaller dogs 3.3-4.9 lbs and 14 weeks and older.
Important safety information
For cats: The most common adverse reaction recorded in clinical trials was vomiting. Other adverse reactions were: lethargy, decreased appetite, weight loss, and diarrhea. Use with caution with concomitant extra-label use of ivermectin.
The safe use of Comfortis in breeding, pregnant, or lactating cats has not been evaluated.
For dogs: The most common adverse reaction reported is vomiting. Other adverse reactions reported in decreasing order of frequency are: depression/lethargy, decreased appetite, incoordination, diarrhea, itching, trembling, excessive salivation and seizures.
Following concomitant extra-label use of ivermectin with Comfortis, some dogs have experienced the following clinical signs: trembling/twitching, salivation/ drooling, seizures, incoordination, excessive dilation of pupils, blindness and disorientation. Post-approval experience continues to support the safety of Comfortis when used concurrently with heartworm preventatives according to label directions.
Use with caution in breeding females and dogs with pre-existing epilepsy. The safe use of Comfortis in breeding males has not been evaluated.
View full product label for complete safety information